Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Postsurgical Pain Due to Third Molar Extraction

NCT number NCT01900795
Study type Interventional
Source Purdue Pharma LP
Contact
Status Terminated
Phase Phase 2
Start date July 2013
Completion date November 2013